Lin28 regulates HER2 and promotes malignancy through multiple mechanisms (Q39328419)

11 September 2017

Lin28 regulates HER2 and promotes malignancy through multiple mechanisms (English)

1 reference

11 September 2017

Chen Feng

1

1 reference

11 September 2017

Veronique Neumeister

2

1 reference

11 September 2017

Wei Ma

3

1 reference

11 September 2017

Jie Xu

4

1 reference

11 September 2017

Lingeng Lu

5

1 reference

11 September 2017

Jennifer Bordeaux

6

1 reference

11 September 2017

Nita J Maihle

7

1 reference

11 September 2017

David L Rimm

8

1 reference

11 September 2017

Yingqun Huang

9

1 reference

11 September 2017

1 July 2012

1 reference

11 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Cell Cycle

1 reference

11 September 2017

11

1 reference

11 September 2017

13

1 reference

11 September 2017

2486-2494

1 reference

Lin28 promotes transformation and is associated with advanced human malignancies

11 September 2017

1 reference

Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies

21 January 2018

1 reference

Temporally regulated expression of Lin-28 in diverse tissues of the developing mouse

21 January 2018

1 reference

The let-7 family of microRNAs

21 January 2018

1 reference

Genome-wide studies reveal that Lin28 enhances the translation of genes important for growth and survival of human embryonic stem cells.

21 January 2018

1 reference

The Lin28/let-7 axis regulates glucose metabolism

21 January 2018

1 reference

Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma

21 January 2018

1 reference

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma

21 January 2018

1 reference

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

21 January 2018

1 reference

Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells

21 January 2018

1 reference

LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms

21 January 2018

1 reference

LIN28B promotes colon cancer progression and metastasis

21 January 2018

1 reference

Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer

21 January 2018

1 reference

Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II.

21 January 2018

1 reference

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

21 January 2018

1 reference

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

21 January 2018

1 reference

Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms.

21 January 2018

1 reference

Molecular basis for interaction of let-7 microRNAs with Lin28

21 January 2018

1 reference

Emerging paradigms of regulated microRNA processing

21 January 2018

1 reference

Regulation of pre-miRNA Processing.

21 January 2018

1 reference

LIN28 alters cell fate succession and acts independently of the let-7 microRNA during neurogliogenesis in vitro

21 January 2018

1 reference

lin-28 controls the succession of cell fate choices via two distinct activities

21 January 2018

1 reference

Evidence that Lin28 stimulates translation by recruiting RNA helicase A to polysomes

21 January 2018

1 reference

Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells

21 January 2018

1 reference

Determinants of mRNA recognition and translation regulation by Lin28.

21 January 2018

1 reference

Primary trastuzumab resistance: new tricks for an old drug

21 January 2018

1 reference

Biology of HER2 and its importance in breast cancer

21 January 2018

1 reference

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

Quantitative, fluorescence-based in-situ assessment of protein expression

21 January 2018

1 reference

Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancer

21 January 2018

1 reference

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

21 January 2018

1 reference

Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance.

21 January 2018

1 reference

21 January 2018

1 reference

HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents

21 January 2018

1 reference

HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer

21 January 2018

1 reference

Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4161/CC.20893

1 reference

11 September 2017

1 reference